DEPARTMENT OF PHARMACY PRACTICE
The department has the expertise to conduct
the following:
1. Bioequivalence studies of formulations.
2. Phase I studies of new drug entities.
3. Phase IV studies (Post marketing surveillance) for new
drugs and formulations.